Retraction

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6

Retraction Details

Citations (34)

34
Total Citations
6
Post-Retraction
(17.6%)
28
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
4 Within 1 year
1 After 2+ years
1339 Days since retraction (latest)
Circular RNAs in cancer
Yang Guo, Qiang Huang, Heng Yu et al. (9 authors)
MedComm Open Access
Published: Feb 2025
2 citations
1339 days after retraction
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Amir Abbas Hamidi, Negin Taghehchian, Zahra Basirat et al. (5 authors)
Biomarker Research Open Access
Published: Jun 2022
33 citations
366 days after retraction
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
Maria Papaioannou, Angeliki Chorti, Anthoula Chatzikyriakidou et al. (6 authors)
Frontiers in Oncology Open Access
Published: Feb 2022
22 citations
245 days after retraction
MicroRNA as an Important Target for Anticancer Drug Development
Zhiwen Fu, Liu Wang, Shijun Li et al. (6 authors)
Frontiers in Pharmacology Open Access
Published: Aug 2021
105 citations
83 days after retraction
LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR‐126‐5p and activating Wnt/β‐catenin signaling
Yan Lu, Meng Tian, Jiongbo Liu et al. (4 authors)
Journal of Biochemical and Molecular Toxicology
Published: Jul 2021
28 citations
57 days after retraction
MicroRNAs as Potential Biomarkers of Type 2 Diabetes Mellitus
Ziravard N. Tonyan, Yulia A. Nasykhova, Anastasiia A. Mikhailova et al. (4 authors)
Russian Journal of Genetics
Published: Jul 2021
4 citations
28 days after retraction
Computational modeling of molecular structure of microRNA inhibitors selected against microRNA over-expressed in thyroid cancer
Luís Jesuíno de Oliveira Andrade, Alcina Maria Vinhaes Bittencourt, Luís Matos de Oliveira et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Apr 2021
38 days before retraction
Epigenetic signature associated with thyroid cancer progression and metastasis
Hong Zhang, Hongliang Duan, Sen Wang et al. (6 authors)
Seminars in Cancer Biology
Published: Mar 2021
15 citations
68 days before retraction
Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma
Wen-Pu Min, Xiaofeng Wei
Auris Nasus Larynx
Published: Oct 2020
18 citations
229 days before retraction
MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway
Yuhua Zhang, Xiaobo Qin, Juan Jiang et al. (4 authors)
Oncology Letters Open Access
Published: May 2020
17 citations
370 days before retraction
How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
César Seigi Fuziwara, Edna Teruko Kimura
Annals of Translational Medicine Open Access
Published: Mar 2020
2 citations
459 days before retraction
A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers
Jennifer Raisch, Anthony Côté-Biron, Nathalie Rivard
Cancers Open Access
Published: Aug 2019
63 citations
660 days before retraction
Downregulation of microRNA‑629‑5p in colorectal cancer and prevention of the malignant phenotype by direct targeting of low‑density lipoprotein receptor‑related protein 6
Guoqiang Yan, Chenyao Li, Yuhang Zhao et al. (5 authors)
International Journal of Molecular Medicine Open Access
Published: Jun 2019
9 citations
716 days before retraction
Paper citing miR-126 inhibits papillary thyroid carcinoma growt...
Unknown Authors
Unknown Journal
Published: Jun 2019
716 days before retraction
MicroRNA signature predicts survival in papillary thyroid carcinoma
Chengfeng Xiong, Gengming Cai, Junjia Zhang et al. (4 authors)
Journal of Cellular Biochemistry
Published: May 2019
16 citations
748 days before retraction
Down-regulated <i>HSDL2</i> expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma
Jing Zeng, Xiao Ma, Jinjing Wang et al. (8 authors)
Bioscience Reports Open Access
Published: May 2019
14 citations
748 days before retraction
Knockdown of circPVT1 inhibits progression of papillary thyroid carcinoma by sponging miR-126
Ling Tao, Li Yang, Ping Tian et al. (5 authors)
RSC Advances Open Access
Published: Jan 2019
9 citations
884 days before retraction
MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma
Agnieszka Zembska, Aleksandra Jawiarczyk-Przybyłowska, Beata Wojtczak et al. (4 authors)
Anticancer Research Open Access
Published: Dec 2018
37 citations
889 days before retraction
<i>Retracted</i>: MiR‐141‐3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer <i>via</i> Targeting Yin Yang 1
Ming Fang, Wenlong Huang, Xinchi Wu et al. (7 authors)
The Anatomical Record Open Access
Published: Oct 2018
34 citations
971 days before retraction
Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway
Fukun Chen, Zhiping Feng, Jialun Zhu et al. (7 authors)
Cancer Biology & Therapy Open Access
Published: Sep 2018
111 citations
995 days before retraction
Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer
Runhua Feng, Maneesh Kumarsing Beeharry, Sheng Lu et al. (9 authors)
Cancer Biomarkers
Published: Mar 2018
13 citations
1178 days before retraction
RETRACTED: miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer
Yuanqiang Lin, Kailiang Cheng, Tongtong Wang et al. (7 authors)
Biomedicine & Pharmacotherapy
Published: Oct 2017
33 citations
1330 days before retraction
The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies
Shaghayegh Pishkari, Mahdi Paryan, Mehrdad Hashemi et al. (5 authors)
Journal of Endocrinological Investigation
Published: Jul 2017
68 citations
1403 days before retraction
Role of microRNAs in endocrine cancer metastasis
Cilene Rebouças Lima, Cibele Crastequini Gomes, Marinilce Fagundes dos Santos
Molecular and Cellular Endocrinology Open Access
Published: Mar 2017
68 citations
1538 days before retraction
Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion
Jinlu Ma, Wenyan Lü, Dongquan Chen et al. (5 authors)
Journal of Cellular Biochemistry Open Access
Published: Mar 2017
58 citations
1555 days before retraction
microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6.
Yue Fan, Chenye Shi, Tianyu Li et al. (4 authors)
PubMed
Published: Jan 2017
40 citations
1614 days before retraction
MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.
Guoqing Sui, Dan Fei, Feng Guo et al. (7 authors)
PubMed
Published: Jan 2017
59 citations
1614 days before retraction
MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.
Jia Liu, Qun Li, Rui Li et al. (5 authors)
PubMed
Published: Jan 2017
40 citations
1614 days before retraction
Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer
Nijiro Nohata, Yusuke Goto, J. Silvio Gutkind
Journal of Human Genetics
Published: Oct 2016
20 citations
1694 days before retraction
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
Roberto Gambari, Eleonora Brognara, Demetrios�� Spandidos et al. (4 authors)
International Journal of Oncology Open Access
Published: May 2016
216 citations
1856 days before retraction
Post-transcriptional regulation of Wnt co-receptor LRP6 and RNA-binding protein HuR by <i>miR-29b</i> in intestinal epithelial cells
Yanwu Li, Gang Chen, Junyao Wang et al. (9 authors)
Biochemical Journal Open Access
Published: Apr 2016
28 citations
1871 days before retraction
MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma
Yingbin Diao, Hongyu Fu, Qian Wang
American Journal of Therapeutics Open Access
Published: Apr 2016
26 citations
1871 days before retraction
microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.
Su Dong, Xianying Meng, Shuai Xue et al. (6 authors)
PubMed
Published: Jan 2016
30 citations
1980 days before retraction
MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1
Qian Jiang, Miao He, Mengtao Ma et al. (11 authors)
Oncology Reports Open Access
Published: Dec 2015
70 citations
1991 days before retraction
Quick Stats
Total Citations: 34
Years Since Retraction: 4.5 years
Open Access: Yes
Last Checked: Jul 24, 2025